[18F]JNJ-64511070

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for [18F]JNJ-64511070, covering 2025-04-27 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070 [Phase 1]

See pricing